09/03/2025 12:09 PM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/28/2025 3:13 PM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/11/2025 6:29 AM | Immunovant (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/11/2025 6:14 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/30/2025 4:56 PM | Immunovant (Issuer) Venker Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/25/2025 4:10 PM | Geffner Michael (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/25/2025 4:11 PM | Immunovant (Issuer) Stout Jay S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2025 3:02 PM | Immunovant (Subject) Macias William L. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2025 4:34 PM | Immunovant (Subject) Macias William L. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2025 4:42 PM | Immunovant (Subject) Macias William L. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2025 6:14 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
05/29/2025 6:30 AM | Immunovant (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
05/21/2025 3:24 PM | Immunovant (Subject) MIGAUSKY GEORGE V (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/05/2025 6:30 PM | Immunovant (Issuer) Susman Robert Graham (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/05/2025 6:30 PM | Bauer Jake (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/05/2025 6:30 PM | Girao Tiago (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/28/2025 4:01 PM | Immunovant (Issuer) Susman Robert Graham (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/28/2025 4:02 PM | Bauer Jake (Reporting) Immunovant (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/28/2025 4:03 PM | Girao Tiago (Reporting) Immunovant (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/21/2025 6:18 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/21/2025 6:54 AM | Immunovant (Subject) Roivant Sciences Ltd. (Filed by) Roivant Sciences Ltd. (Filed by)
| Form SCHEDULE 13D/A | |
04/17/2025 3:07 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2025 3:08 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/11/2025 3:05 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2025 3:50 PM | Geffner Michael (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2025 3:51 PM | Immunovant (Issuer) Stout Jay S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2025 3:53 PM | Gloria Melanie (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2025 3:55 PM | Immunovant (Issuer) Van Tuyl Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2025 3:41 PM | Fromkin Andrew J. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2025 3:43 PM | Hughes Douglas J. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2025 3:44 PM | Immunovant (Issuer) Pande Atul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2025 3:46 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2025 3:48 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2025 3:37 PM | Immunovant (Issuer) Torti Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2025 6:51 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/11/2025 3:18 PM | Fromkin Andrew J. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2025 3:17 PM | Fromkin Andrew J. (Reporting) Immunovant (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2025 9:01 AM | FMR LLC (Filed by) Immunovant (Subject)
| Form SCHEDULE 13G/A | |
02/06/2025 5:45 AM | Immunovant (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
02/06/2025 5:37 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/24/2025 4:20 PM | Immunovant (Filer)
| Form 424B3 | |
|
01/24/2025 4:24 PM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/24/2025 3:22 PM | Geffner Michael (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2025 3:23 PM | Immunovant (Issuer) Stout Jay S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/21/2025 4:16 PM | Immunovant (Filer)
| Form D Notice of Exempt Offering of Securities | |
01/15/2025 3:36 PM | Immunovant (Issuer) Roivant Sciences Ltd. (Reporting) Roivant Sciences Ltd. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/15/2025 3:30 PM | Immunovant (Subject) Roivant Sciences Ltd. (Filed by) Roivant Sciences Ltd. (Filed by)
| Form SCHEDULE 13D/A | |
01/14/2025 7:09 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/13/2025 7:07 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2024 4:01 PM | Immunovant (Issuer) Van Tuyl Christopher (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/18/2024 4:02 PM | Immunovant (Issuer) Van Tuyl Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2024 3:11 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2024 3:12 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2024 3:09 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2024 3:08 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2024 4:11 PM | Gloria Melanie (Reporting) Immunovant (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
11/20/2024 4:15 PM | Gloria Melanie (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2024 5:42 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2024 5:49 AM | Immunovant (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/25/2024 3:21 PM | Immunovant (Issuer) Stout Jay S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/25/2024 3:23 PM | Geffner Michael (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/25/2024 3:25 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2024 3:27 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2024 3:28 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2024 3:30 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2024 3:31 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |